Soc Telemed Inc
NASDAQ:TLMD
Soc Telemed Inc
NASDAQ:TLMD
Price:
3 USD
Updated:
May 2, 2024
Section:
Relative Value
There is not enough data to reliably calculate the relative value of TLMD.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
TLMD
Relative Value
Base Case
Not Available
Valuation Multiples
Multiples Across Competitors
TLMD Competitors Multiples
Soc Telemed Inc Competitors
Soc Telemed Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Soc Telemed Inc
NASDAQ:TLMD
|
296.6m USD | 2.4 | -3.4 | -5.6 | -4.7 | |
| US |
|
Cigna Corp
NYSE:CI
|
102.6B USD | 0.5 | 19.8 | 10.2 | 13.6 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
97.2B EUR | 0.5 | 20.1 | 10.3 | 13.8 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
69.4B USD | 0.2 | 8.4 | 7.7 | 7.7 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
11.4B EUR | 0.6 | 22.8 | 6.8 | 16.2 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
16.9B USD | 1.4 | 38.9 | 11.9 | 17.9 | |
| DE |
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
15.8B EUR | 0.7 | -26.6 | 10.1 | 22.6 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
15B USD | 1.6 | 17.9 | 10.7 | 14.5 | |
| US |
|
DaVita Inc
NYSE:DVA
|
12.6B USD | 1 | 18.1 | 8.7 | 12.8 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.8B EUR | 0.6 | 23.7 | 7 | 16.5 | |
| US |
|
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | 4.4 | -18.6 | -23.3 | -21.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
